|
Delayed
Bombay S.E.
06:02:23 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 35.05 INR | -4.44% |
|
-15.62% | -19.43% |
Company Valuation: Gujarat Terce Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 51.65 | 194 | 123.6 | 392.9 | 453.7 | 240.8 |
| Change | - | 275.72% | -36.29% | 217.83% | 15.47% | -46.93% |
| Enterprise Value (EV) 1 | 86.15 | 245.7 | 176 | 430.7 | 450.2 | 211.6 |
| Change | - | 185.15% | -28.34% | 144.64% | 4.53% | -52.99% |
| P/E | -2.05x | 22.2x | -7.4x | 161x | -46.3x | 10.6x |
| PBR | 0.67x | 2.27x | 1.8x | 5.53x | 7x | 2.47x |
| PEG | - | -0x | 0x | -1x | 0x | -0x |
| Capitalization / Revenue | 0.21x | 0.48x | 0.26x | 0.82x | 0.9x | 0.51x |
| EV / Revenue | 0.34x | 0.61x | 0.38x | 0.9x | 0.9x | 0.45x |
| EV / EBITDA | -2.92x | 22x | -8.15x | 34x | 11.6x | 5.65x |
| EV / EBIT | -2.76x | 29.2x | -6.98x | 47.9x | 12.9x | 6.36x |
| EV / FCF | -10.7x | -7.43x | 84.1x | 24.5x | 8.13x | 36.1x |
| FCF Yield | -9.39% | -13.5% | 1.19% | 4.08% | 12.3% | 2.77% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3.4 | 1.176 | -2.253 | 0.328 | -1.32 | 2.92 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 251.8 | 401.3 | 467.8 | 479.7 | 502 | 474.7 |
| EBITDA 1 | -29.46 | 11.18 | -21.59 | 12.67 | 38.83 | 37.48 |
| EBIT 1 | -31.23 | 8.416 | -25.24 | 8.99 | 34.98 | 33.25 |
| Net income 1 | -25.2 | 8.723 | -16.72 | 2.434 | -9.787 | 22.02 |
| Net Debt 1 | 34.51 | 51.63 | 52.42 | 37.76 | -3.49 | -29.11 |
| Reference price 2 | 6.96 | 26.15 | 16.66 | 52.95 | 61.14 | 30.90 |
| Nbr of stocks (in thousands) | 7,420 | 7,420 | 7,420 | 7,420 | 7,420 | 7,791 |
| Announcement Date | 8/11/21 | 8/1/22 | 8/1/23 | 8/24/24 | 7/28/25 | 7/28/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.88M | |
| 35.75x | 12.79x | 26.94x | 0.55% | 1,106B | |
| 37.14x | 6.26x | 17.62x | 2.1% | 612B | |
| 36.08x | 8.31x | 17.14x | 2.43% | 500B | |
| 20.6x | 4.98x | 12.38x | 2.63% | 367B | |
| 104.7x | 5.86x | 25.15x | 2.37% | 354B | |
| 21.05x | 5.51x | 13.55x | 2.9% | 286B | |
| 21.56x | 4.37x | 12.5x | 2.02% | 256B | |
| 26.98x | 6.96x | 12.46x | 2.37% | 230B | |
| -44.72x | 6.87x | 26.59x | 2.15% | 190B | |
| Average | 28.79x | 6.88x | 18.26x | 2.17% | 390.01B | |
| Weighted average by Cap. | 34.40x | 8.11x | 19.89x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GUJTERC6 Stock
- Valuation Gujarat Terce Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
